论文部分内容阅读
这个报告是根据在美国、加拿大、以色列、苏格兰、意大利、德国和新西兰受试的26,294名内科住院病号的观察结果。其中百分之四十六的人起码肌注过一次。肌注给药占青霉素G 普鲁卡因、汞利尿剂、维生素B_(12)、链霉素硫酸盐、粘菌素M 钠、度冷丁、先锋霉素Ⅱ,东莨菪硷氢澳酸、卡那霉素、右旋糖酐铁注射液等药物给药方法的80%以上。经肌内注射的26,294名病人中有12,134名最少肌注过一次(46%)。表1列出的32种药物,每一种药物有一百或更多的病人使用,其中肌内注射给药的至少占30%。(参见表1)局部合并症——12,134人中发生不良反应者有48
The report is based on the observation of 26,294 inpatient medical inpatients in the United States, Canada, Israel, Scotland, Italy, Germany and New Zealand. Forty-six percent of them were intramuscularly injected at least once. Intramuscular administration of penicillin G procaine, mercury diuretics, vitamin B_ (12), streptomycin sulfate, sodium colistin sodium, meperidine, cephalosporin II, scopolamine hydrogen acid, card Nystatin, iron dextran and other drug delivery methods of more than 80%. Of the 26,294 patients injected intramuscularly, 12,134 had the least intramuscular injection (46%). The 32 drugs listed in Table 1, each with one hundred or more patients, account for at least 30% of intramuscular injections. (See Table 1) Local Comorbidity - 12 of 134 people who developed adverse reactions 48